This move is archived. Current quotes and coverage live on the stock page.
Get TELY alerts:
TelyRx Holdings Inc. faces a significant downturn as its stock drops over 6% in a single trading day.
In today's trading session, TelyRx Holdings Inc. (TELY.TO) saw its stock price decline by 6.12%, closing at CA$2.30. This drop raises concerns among investors about the company's short-term performance. Although recent financial results show revenue growth, they also reflect substantial net losses.
Investor takeaway: Today's decline in TelyRx's stock price highlights the volatility and risks associated with investing in early-stage biotech firms, especially when financial results do not meet investor expectations.
Advertisement
TelyRx Holdings Inc.
TELY.TO
TELY.TO
TelyRx Holdings Inc.
WealthAwesomeMarket cap
$65.94M
52W high
$4.25
52W low
$2.00
1W change
-4.00%
Analyst Price Targets
Based on analyst covering TELY
Wall Street analysts forecast TELY stock price to rise 150.0% over the next 12 months.
Consensus
BullishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$6.00
+150.0% Upside
Current Price
C$2.40
Last close
Analyst ratings and price targets are updated periodically. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on TELY's historical volatility
30-Day Vol
99.8%
Annualized
90-Day Vol
95.3%
Annualized
Trend (90d)
+17.9%
Annualized drift
90d Mean
C$2.56
Expected price
| Horizon | Expected | 68% Range (1ฯ) |
|---|---|---|
| 30 trading days | C$2.45 | C$1.74 โ C$3.46 |
| 60 trading days | C$2.50 | C$1.54 โ C$4.08 |
| 90 trading days | C$2.56 | C$1.41 โ C$4.65 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ยฑ1ฯ, 95% band = ยฑ2ฯ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Advertisement
TelyRx Holdings Inc. stock down 6.12% today
The company's market cap now stands at approximately CA$65 million, indicating a challenging environment for growth amidst ongoing financial losses.
Bull case
If TelyRx can keep increasing its revenue as indicated in their recent financial reports, it might attract more investor interest and help stabilize its stock price.
Bear case
The ongoing net losses and the absence of positive news could lead to further declines in the stock price, as investors may lose confidence in the company's ability to turn a profit.
Advertisement
Recent Financial Performance
TelyRx recently reported substantial revenue growth, with Q1 2026 revenues reaching CA$19.4 million, up from CA$6.9 million in the same quarter last year. However, the company also reported a net loss of CA$4.7 million, which has contributed to investor skepticism about its profitability potential. For more details, check out the full earnings report.
Market Sentiment and Future Outlook
The market's reaction to TelyRx's financial results shows a cautious sentiment among investors. While revenue increases are a positive sign, the persistent net losses raise concerns about the company's long-term viability. Investors are advised to monitor future announcements closely, especially regarding profitability strategies. For further insights, visit our TelyRx stock page.
Best next step
Keep exploring this topic
If you want to go deeper, these are the most useful follow-up pages and tools for this topic.
Broker comparison
Best trading platforms in Canada
Compare $0-commission brokers before you act on a ticker story.
Safe cash
Best GIC rates in Canada
If the story makes you want to de-risk, compare guaranteed rates next.
HISA roundup
Best high-interest savings accounts
Keep dry powder in a no-fee savings account instead of chequing.
TFSA room
Check TFSA contribution room
Shelter the next contribution before you buy.
Advertisement
Wealth Awesome
Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.
View Full Profile โโ Reviewed by Certified Financial Professionals
This content has been reviewed by CFAยฎ charterholders and Certified Financial Planners (CFPยฎ) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFAยฎ charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFPยฎ professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
โ ๏ธ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.
